Literature DB >> 12492581

FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.

Paolo Arrigoni1, Chiara Beretta, Daniela Silvestri, Vincenzo Rossi, Carmelo Rizzari, Maria Grazia Valsecchi, Giovanni Cazzaniga, Andrea Biondi.   

Abstract

We evaluated the incidence of FLT3/internal tandem duplication (ITD) mutation in childhood acute myeloid leukaemia (AML) diagnosed over 15 years. FLT3/ITD was found in 10 of 45 (22.2%) non-acute promyelocytic leukaemia (non-APL) patients. The 5-year event-free survival of non-APL patients was higher in FLT3/ITD-negative versus -positive patients (48.9%, SE 8.9, vs 20.0%, SE 16.1, P = 0.03). In childhood APL, FLT3/ITD incidence was higher than in non-APL, although not statistically significant (10 out of 29 patients, 34.5%, P = 0.29). In APL patients, FLT3/ITD was strongly correlated to a higher white blood cell count at diagnosis and the M3 French-American-British subtype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492581     DOI: 10.1046/j.1365-2141.2003.04032.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  Biology, clinical relevance, and molecularly targeted therapy in acute leukemia with FLT3 mutation.

Authors:  Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

Review 2.  Clinical significance of FLT3 in leukemia.

Authors:  Hitoshi Kiyoi; Masamitsu Yanada; Kazutaka Ozekia
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

3.  FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.

Authors:  Matthew A Kutny; Barry K Moser; Kristina Laumann; James H Feusner; Alan Gamis; John Gregory; Richard A Larson; Bayard L Powell; Wendy Stock; Cheryl L Willman; William G Woods; Soheil Meshinchi
Journal:  Pediatr Blood Cancer       Date:  2012-02-29       Impact factor: 3.167

Review 4.  How I treat children and adolescents with acute promyelocytic leukaemia.

Authors:  Oussama Abla; Raul C Ribeiro
Journal:  Br J Haematol       Date:  2013-09-30       Impact factor: 6.998

Review 5.  Global characteristics of childhood acute promyelocytic leukemia.

Authors:  L Zhang; A Samad; M S Pombo-de-Oliveira; G Scelo; M T Smith; J Feusner; J L Wiemels; C Metayer
Journal:  Blood Rev       Date:  2014-09-30       Impact factor: 8.250

6.  Possible involvement of RasGRP4 in leukemogenesis.

Authors:  Naoko Watanabe-Okochi; Toshihiko Oki; Yukiko Komeno; Naoko Kato; Koichiro Yuji; Ryoichi Ono; Yuka Harada; Hironori Harada; Yasuhide Hayashi; Hideaki Nakajima; Tetsuya Nosaka; Jiro Kitaura; Toshio Kitamura
Journal:  Int J Hematol       Date:  2009-04-07       Impact factor: 2.490

Review 7.  Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

8.  Characteristics and Prognosis of Adult Acute Myeloid Leukemia with Internal Tandem Duplication in the FLT3 Gene.

Authors:  Adhra Al-Mawali; David Gillis; Ian Lewis
Journal:  Oman Med J       Date:  2013-11

Review 9.  Incidence of FLT3 and nucleophosmin gene mutations in childhood acute myeloid leukemia: Serbian experience and the review of the literature.

Authors:  Nada Krstovski; Natasa Tosic; Dragana Janic; Lidija Dokmanovic; Milos Kuzmanovic; Vesna Spasovski; Sonja Pavlovic
Journal:  Med Oncol       Date:  2009-06-26       Impact factor: 3.064

10.  Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia.

Authors:  Eun Sun Yoo
Journal:  Korean J Pediatr       Date:  2011-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.